HRT Financial LP nets sale of Onconetix shares
HRT Financial LP, a ten percent owner of Onconetix, Inc., reported several open-market trades in Class A Shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HRT Financial LP, a ten percent owner of Onconetix, Inc., reported several open-market trades in Class A Shares. On April 16, 2026 and April 20, 2026 it sold a total of 148,329 shares at about $0.73–$0.75 per share, and on April 17, 2026 it purchased 34,636 shares at $0.73. Overall, this was a net sale of 113,693 shares, leaving HRT Financial LP with 83,359 Class A Shares held directly after the last reported transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Shares | 94,462 | $0.75 | $71K |
| Purchase | Class A Shares | 34,636 | $0.73 | $25K |
| Sale | Class A Shares | 53,867 | $0.73 | $39K |
Key Figures
Key Terms
open-market sale financial
open-market purchase financial
ten percent owner financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did HRT Financial LP report for Onconetix (ONCO)?
What is HRT Financial LP’s remaining Onconetix (ONCO) stake after these trades?
Were any derivative securities involved in HRT Financial LP’s Onconetix (ONCO) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.